Health Care stocks
690 US-listed companies in the health care sector reported $4.32tn of revenue in their latest fiscal years. UnitedHealth Group is the largest, with $447.6bn. Among companies with at least $100m of revenue, the median grew 9.7% and kept 1.2% of revenue as net income.
Companies690
Combined revenue$4.32tn
Median revenue growth9.7%
Median net margin1.2%
Median return on equity4.6%
Largest health care companies
| # | Company | Revenue | Growth | Net margin | ROE | Fiscal year |
|---|---|---|---|---|---|---|
| 1 | UnitedHealth GroupUNH | $447.6bn | 11.8% | 2.7% | 12.2% | 2025 |
| 2 | McKessonMCK | $403.4bn | 12.4% | 1.2% | — | 2026 |
| 3 | CVS HealthCVS | $402.1bn | 7.8% | 0.4% | 2.3% | 2025 |
| 4 | CencoraCOR | $321.3bn | 9.3% | 0.5% | 144.3% | 2025 |
| 5 | CignaCI | $274.9bn | 11.2% | 2.2% | 14.4% | 2025 |
| 6 | Cardinal HealthCAH | $254.2bn | 14.2% | 0.7% | — | 2026 |
| 7 | Elevance HealthELV | $199.1bn | 12.5% | 2.8% | 13.3% | 2025 |
| 8 | Centene CorporationCNC | $194.8bn | 19.4% | −3.4% | −28.8% | 2025 |
| 9 | HumanaHUM | $129.7bn | 10.1% | 0.9% | 7.0% | 2025 |
| 10 | Johnson & JohnsonJNJ | $94.2bn | 6.0% | 28.5% | 35.0% | 2025 |
| 11 | HCA HealthcareHCA | $75.6bn | 7.1% | 9.0% | — | 2025 |
| 12 | Lilly (Eli)LLY | $65.2bn | 44.7% | 31.7% | 101.2% | 2025 |
| 13 | Merck & Co.MRK | $65.0bn | 1.3% | 28.1% | 36.9% | 2025 |
| 14 | PfizerPFE | $62.6bn | −1.6% | 12.4% | 8.9% | 2025 |
| 15 | AbbVieABBV | $61.2bn | 8.6% | 6.9% | — | 2025 |
| 16 | Astrazeneca PLCAZN | $58.7bn | 8.6% | 17.4% | 22.9% | 2025 |
| 17 | Bristol Myers SquibbBMY | $48.2bn | −0.2% | 14.6% | 40.5% | 2025 |
| 18 | Novo Nordisk A SNVO | $46.8bn | 11.1% | 33.1% | 61.6% | 2025 |
| 19 | Molina Healthcare, Inc.MOH | $45.4bn | 11.7% | 1.0% | 11.0% | 2025 |
| 20 | Thermo Fisher ScientificTMO | $44.6bn | 3.9% | 15.0% | 13.0% | 2025 |
| 21 | Abbott LaboratoriesABT | $44.3bn | 5.7% | 14.7% | 13.1% | 2025 |
| 22 | GSK plcGSK | $43.1bn | 7.5% | 17.5% | 38.5% | 2025 |
| 23 | AmgenAMGN | $36.8bn | 10.0% | 21.0% | 106.1% | 2025 |
| 24 | MedtronicMDT | $36.4bn | 8.4% | 13.2% | 9.8% | 2026 |
| 25 | Gilead SciencesGILD | $29.4bn | 2.4% | 28.9% | 40.5% | 2025 |
Industries in health care
- Managed Health Care8 companies, $1.03tn
- Health Care Distributors9 companies, $1.03tn
- Health Care Services48 companies, $779.7bn
- Pharmaceuticals86 companies, $591.9bn
- Health Care Equipment153 companies, $304.2bn
- Biotechnology268 companies, $229.8bn
- Life Sciences Tools & Services60 companies, $145.6bn
- Health Care Facilities13 companies, $117.3bn
- Hospitals5 companies, $48.0bn
- Health Care Supplies13 companies, $22.6bn
- Health Care Technology26 companies, $22.2bn
- Pharmaceutical preparations1 company, $0